Partial Reinforcement Strategy Feasible for Chronic Insomnia

This article originally appeared here.
Share this content:
Partial Reinforcement Strategy Feasible for Chronic Insomnia
Partial Reinforcement Strategy Feasible for Chronic Insomnia

TUESDAY, Aug. 11, 2015 (HealthDay News) -- A partial reinforcement strategy with 10 mg zolpidem seems to be effective for maintenance therapy for chronic insomnia, according to a study published online July 7 in Sleep Medicine.

Michael Perlis, Ph.D., from the University of Pennsylvania in Philadelphia, and colleagues examined management of chronic insomnia in the long term, comparing a partial reinforcement strategy with nightly and intermittent dosing strategies. Seventy-four individuals with chronic insomnia received 10 mg zolpidem for four weeks. Responders were randomly allocated to 12 weeks of nightly dosing with 10 mg or 5 mg; intermittent dosing with 10 mg (three to five days weekly); or partial reinforcement dosing with 10 mg (nightly pill use with 50 percent active medication and 50 percent placebo).

The researchers found that in 55 compliant individuals, treatment response was maintained over time for all four strategies. Of those who remained in remission, poorer sleep continuity was seen for subjects in the intermittent dosing group.

"While best considered a preliminary study, the present findings suggest that the partial reinforcement strategy may be a viable means toward maintaining treatment gains over time with less active medication," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »